(Q44256448)

1 December 2017

title

Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation (English)

1 reference

1 December 2017

1 reference

1 reference

Flavio Vincenti

1

1 reference

1 December 2017

Daniel Pace

series ordinal

2

1 reference

1 December 2017

Jytte Birnbaum

series ordinal

3

1 reference

1 December 2017

Marianne Lantz

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

American Journal of Transplantation

1 December 2017

published in

1 reference

1 December 2017

volume

3

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

50-52

1 reference

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

inferred from DOI database lookup

7 January 2021

based on heuristic

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

inferred from DOI database lookup

7 January 2021

based on heuristic

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30109.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-6143.2003.30109.X

1 reference

1 December 2017

1 reference